These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 9265151)

  • 1. [Hypoxia and inflammation--causes of acute and chronic pulmonary artery hypertension].
    Ziesche R
    Pneumologie; 1997 May; 51(5):495-8. PubMed ID: 9265151
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitric oxide and endothelin-1 in pulmonary hypertension.
    Giaid A
    Chest; 1998 Sep; 114(3 Suppl):208S-212S. PubMed ID: 9741571
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary endothelial dysfunction: hypertension and heart failure.
    Boulanger CM
    J Mol Cell Cardiol; 1999 Jan; 31(1):39-49. PubMed ID: 10072714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A role of the endothelium in the development of pulmonary hypertension in patients with chronic obstructive lung diseases].
    Karoli NA; Rebrov AP
    Klin Med (Mosk); 2004; 82(8):8-14. PubMed ID: 15468716
    [No Abstract]   [Full Text] [Related]  

  • 5. Upregulation of endothelial nitric oxide synthase and endothelin-1 in pulmonary hypertension secondary to heart failure in aorta-banded rats.
    Dai ZK; Tan MS; Chai CY; Yeh JL; Chou SH; Chiu CC; Jeng AY; Chen IJ; Wu JR
    Pediatr Pulmonol; 2004 Mar; 37(3):249-56. PubMed ID: 14966819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide and hypoxic pulmonary hypertension.
    Leeman M; Naeije R
    Eur Respir J; 1995 Apr; 8(4):513-4. PubMed ID: 7545132
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of increased pulmonary flow on the expression of endothelial nitric oxide synthase and endothelin-1 in the rat.
    Dai ZK; Tan MS; Chai CY; Chen IJ; Jeng AY; Wu JR
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():289S-293S. PubMed ID: 12193106
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of flow-induced pulmonary arterial vasculopathy after flow correction in piglets.
    Mercier O; Sage E; de Perrot M; Tu L; Marcos E; Decante B; Baudet B; Hervé P; Dartevelle P; Eddahibi S; Fadel E
    J Thorac Cardiovasc Surg; 2009 Jun; 137(6):1538-46. PubMed ID: 19464477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary pulmonary hypertension and its management].
    Crespo Martínez C; Morales León V; Alonso Ramos H; Alonso Ortiz B; Molero Gómez R
    Farm Hosp; 2004; 28(1):48-55. PubMed ID: 15012178
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary hypertension: the role of nitric oxide in adults].
    Neidecker J
    Rev Esp Anestesiol Reanim; 2001 Dec; 48(10):457-9. PubMed ID: 11792299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of endothelin-1 on endothelium-derived vascular responsiveness in man.
    Krum H; Cranswick N; Pellizzer AM
    Clin Sci (Lond); 1998 Aug; 95(2):151-6. PubMed ID: 9680496
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The role of nitric oxide in regulating pulmonary functions].
    Nevzorova VA; Zuga MV; Gel'tser BI
    Ter Arkh; 1997; 69(3):68-73. PubMed ID: 9229838
    [No Abstract]   [Full Text] [Related]  

  • 13. Bench to bedside: nitric oxide in emergency medicine.
    Lopez BL; Christopher TA; Griswold SK; Ma XL
    Acad Emerg Med; 2000 Mar; 7(3):285-93. PubMed ID: 10730840
    [No Abstract]   [Full Text] [Related]  

  • 14. [Pathophysiology of pulmonary hypertension: advances and prospects].
    Montani D; Guignabert C; Perros F; Humbert M
    Rev Mal Respir; 2012 Oct; 29(8):950-2. PubMed ID: 23101636
    [No Abstract]   [Full Text] [Related]  

  • 15. Advanced cystic fibrosis lung disease in children.
    Hamutcu R; Woo MS
    Curr Opin Pulm Med; 2001 Nov; 7(6):448-53. PubMed ID: 11706324
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitric oxide and control of pulmonary vascular resistance.
    Cremona G
    Monaldi Arch Chest Dis; 2001 Apr; 56(2):158-64. PubMed ID: 11499308
    [No Abstract]   [Full Text] [Related]  

  • 17. [Protective role of myelocytic nitric oxide synthases in pulmonary hypertension due to lung diseases and/or hypoxia].
    Ogoshi T; Tsutsui M; Yatera K; Mukae H
    Nihon Yakurigaku Zasshi; 2020; 155(2):69-73. PubMed ID: 32115480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Acute pulmonary hypertensive heart disease. Physiopathology].
    Galland F; De León A; Medrano GA
    Arch Inst Cardiol Mex; 1969; 39(1):142-8. PubMed ID: 5792232
    [No Abstract]   [Full Text] [Related]  

  • 19. [Certain problems of pathogenesis by hypertension of the lesser circulation in chronic pneumonia].
    Dembo AG; Shapkaĭts IuM
    Ter Arkh; 1974; 46(3):67-72. PubMed ID: 4828500
    [No Abstract]   [Full Text] [Related]  

  • 20. The pathogenesis of HIV-associated pulmonary hypertension.
    Klings ES; Farber HW
    Adv Cardiol; 2003; 40():71-82. PubMed ID: 14533547
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.